Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* AGC or EGC confirmed by endoscopy~* Histologically confirmed adenocarcinoma of stomach~* Helicobacter pylori infection was confirmed by biopsy and CLO~* Pre op CT stage: IA, IB, II, IIIA according to UICC TNM classification system~* Pre op biopsy (body LC side) shows either intestinal metaplasia or glandular atrophy (at least grade 1)~* Tumor location is suitable for subtotal gastrectomy- i.e. at or distal to lower body~* Informed consent should be signed~Exclusion Criteria:~* Recurrent gastric cancer~* Previous serious side effect to antibiotics~* H. pylori eradication treatment history~* Other malignancy within the past 5 years~* Pregnant or nursing women~* Serious concurrent infection or nonmalignant disease such as liver cirrhosis, renal failure, cardiovascular diseases~* Psychiatric disorder that would preclude compliance

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- H. pylori eradication (Type: ACTIVE_COMPARATOR): None
- placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).